Midatlantic Cardiovascular Associates, Pa — Baltimore, Maryland

Midatlantic Cardiovascular Associates, Pa is a clinical research site located in Baltimore, Maryland, United States 21229.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Midatlantic Cardiovascular Associates, Pa has participated in 3 clinical trials.

Therapeutic areas: Arthritis, Rheumatoid, Atrial Fibrillation, Atrial Flutter.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Midatlantic Cardiovascular Associates, Pa?

Midatlantic Cardiovascular Associates, Pa has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Midatlantic Cardiovascular Associates, Pa conducted?

Midatlantic Cardiovascular Associates, Pa has 3 clinical trials on record. Their work covers Arthritis, Rheumatoid, Atrial Fibrillation, Atrial Flutter.

Is Midatlantic Cardiovascular Associates, Pa accredited by Crixeo Health?

Midatlantic Cardiovascular Associates, Pa has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Midatlantic Cardiovascular Associates, Pa?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.